MedTrace Logo

ABG Oxidative Stress Study Protocol-1

NCT02213523 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2014-08-11

No results posted yet for this study

Summary

This is a proof of concept study that evaluates the response to oxidative stress in healthy men after taking plant concentrates.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Plant concentrate A

Screening for the optimal dosage by starting with with a low dose of 300 mg for one week then switch to 600 mg for one week.

DIETARY_SUPPLEMENT

Plant concentrate B

Screening for the optimal dosage by starting with with a low dose of 300 mg for one week then switch to 600 mg for one week.

DIETARY_SUPPLEMENT

Plant concentrate C

Screening for the optimal dosage by starting with with a low dose of 300 mg for one week then switch to 600 mg for one week.

DIETARY_SUPPLEMENT

Plant concentrate D

Screening for the optimal dosage by starting with with a low dose of 300 mg for one week then switch to 600 mg for one week.

Sponsors & Collaborators

  • Access Business Group

    lead INDUSTRY

Principal Investigators

  • Richard Keech, M.D. · Southbay Pharma Research

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2012-11-30
Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02213523 on ClinicalTrials.gov